| No H2RA (n = 17,683) (57.8%) | H2RA (n = 12,908) (42.2%) | p value |
---|---|---|---|
Age, [median, years (IQR)] | 69 (58–80) | 66 (56–76) | < 0.01 |
Males | 9842 (55.7%) | 7829 (60.7%) | < 0.01 |
Race | Â | Â | < 0.01 |
 American Indian/Alaska Native | 50 (0.3%) | 19 (0.2%) |  |
 Asian | 508 (2.9%) | 374 (2.9%) |  |
 Black/African American | 2062 (11.7%) | 1078 (8.4%) |  |
 Hispanic/Latino | 640 (3.6%) | 498 (3.9%) |  |
 Other | 754 (4.3%) | 657 (5.1%) |  |
 Unknown | 1405 (7.9%) | 1724 (13.4%) |  |
 White | 12,264 (69.4%) | 8558 (66.3%) |  |
Comorbid conditions | |||
 AIDS | 197 (1.1%) | 82 (0.6%) | < 0.01 |
 Cerebrovascular disease | 1942 (11.0%) | 2256 (17.5%) | < 0.01 |
 Chronic pulmonary disease | 5334 (30.2%) | 3257 (25.2%) | < 0.01 |
 Congestive heart failure | 6500 (36.8%) | 3630 (28.1%) | < 0.01 |
 Dementia | 1072 (6.1%) | 373 (2.9%) | < 0.01 |
 Diabetes, chronic complications | 2291 (13.0%) | 1153 (8.9%) | < 0.01 |
 Diabetes no chronic complications | 4629 (26.2%) | 3042 (23.6%) | < 0.01 |
 Malignant cancer | 2870 (16.2%) | 1429 (11.1%) | < 0.01 |
 Metastatic solid tumor | 1334 (7.5%) | 610 (4.7%) | < 0.01 |
 Mild liver disease | 3416 (19.3%) | 1357 (10.5%) | < 0.01 |
 Myocardial infarction | 3147 (17.8%) | 2269 (17.6%) | 0.62 |
 Paraplegia | 653 (3.7%) | 817 (6.3%) | < 0.01 |
 Peptic ulcer disease | 850 (4.8%) | 204 (1.9% ) | < 0.01 |
 Peripheral vascular disease | 2184 (12.4%) | 1748 (13.5%) | < 0.01 |
 Renal disease | 5474 (31.0%) | 2533 (19.6%) | < 0.01 |
 Rheumatic disease | 764 (4.3%) | 405 (3.1%) | < 0.01 |
 Severe liver disease | 2006 (11.3%) | 520 (4.0%) | < 0.01 |
Charlson comorbidity index [median (IQR)] | 6 (5–8) | 5 (4–7) | < 0.01 |
APS III Score [median (IQR)] | 51 (39–68) | 48 (34–70) | < 0.01 |
SAPS II Score [median (IQR)] | 38 (33–48) | 38 (30–47) | < 0.01 |
OASIS Score [median (IQR)] | 33 (27–39) | 35 (29–41) | < 0.01 |
First Day SOFA Score [median (IQR)] | 5 (4–8) | 6 (4–9) | < 0.01 |